News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
886,570 Results
Type
Article (89007)
Company Profile (555)
Press Release (796990)
Multimedia
Podcasts (250)
Webinars (37)
Section
Business (267104)
Career Advice (4167)
Deals (40039)
Drug Delivery (182)
Drug Development (91809)
Employer Resources (208)
FDA (18615)
Job Trends (17503)
News (398963)
Policy (40028)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (3069)
Academic (2)
Accelerated approval (60)
ADA (50)
Adcomms (43)
Allergies (213)
Alliances (56991)
ALS (246)
Alzheimer's disease (2052)
Antibody-drug conjugate (ADC) (604)
Approvals (19029)
Artificial intelligence (943)
ASCO (345)
Autoimmune disease (392)
Automation (71)
Bankruptcy (409)
Best Places to Work (12635)
BIO (80)
BIOSECURE Act (23)
Biosimilars (266)
Biotechnology (336)
Bladder cancer (220)
Brain cancer (87)
Breast cancer (872)
Cancer (6910)
Cardiovascular disease (583)
Career advice (3604)
Career pathing (55)
CAR-T (401)
CDC (77)
Celiac Disease (3)
Cell therapy (1121)
Cervical cancer (60)
Clinical research (79533)
Collaboration (2515)
Commercialization (3)
Company closure (8)
Compensation (1620)
Complete response letters (118)
COVID-19 (3047)
CRISPR (130)
C-suite (1400)
Cystic fibrosis (170)
Data (9148)
Decentralized trials (3)
Denatured (96)
Depression (207)
Dermatology (111)
Diabetes (740)
Diagnostics (7695)
Digital health (75)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (478)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (338)
Earnings (102738)
Editorial (81)
Employer branding (25)
Employer resources (178)
Events (139146)
Executive appointments (1249)
FDA (22961)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (23)
Frontotemporal dementia (37)
Funding (2052)
Gene editing (285)
Generative AI (95)
Gene therapy (883)
GLP-1 (1306)
Government (5574)
Grass and pollen (8)
Guidances (428)
Healthcare (21281)
Hematology (198)
HIV (106)
Huntington's disease (73)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (122)
Immunology and inflammation (371)
Immuno-oncology (124)
Indications (231)
Infectious disease (3463)
Inflammatory bowel disease (248)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (343)
Interviews (823)
IPO (18022)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (27)
Labor market (130)
Layoffs (699)
Leadership (56)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (915)
Lymphoma (497)
Machine learning (70)
Management (69)
Manufacturing (1330)
Marketing (9)
MASH (233)
Medical affairs (1)
Medical device (15334)
Medtech (15546)
Mergers & acquisitions (23401)
Metabolic disorders (1904)
mRNA (283)
Multiple sclerosis (217)
NASH (24)
Neurodegenerative disease (551)
Neuropsychiatric disorders (133)
Neuroscience (3904)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5150)
Now hiring (85)
Obesity (902)
Opinion (385)
Ovarian cancer (257)
Pain (299)
Pancreatic cancer (379)
Parkinson's disease (434)
Partnered (43)
Patents (704)
Patient recruitment (855)
Peanut (72)
People (68288)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24567)
Phase 2 (34543)
Phase 3 (25978)
Pipeline (10685)
Policy (409)
Postmarket research (3561)
Preclinical (11017)
Press Release (72)
Prostate cancer (367)
Psychedelics (81)
Radiopharmaceuticals (387)
Rare diseases (1361)
Real estate (7467)
Recruiting (83)
Regulatory (30811)
Reports (78)
Research institute (2782)
Resumes & cover letters (655)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (200)
Series A (350)
Series B (254)
Service/supplier (15)
Sickle cell disease (135)
Special edition (33)
Spinal muscular atrophy (193)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (153)
Tariffs (104)
The Weekly (151)
Vaccines (1342)
Venture capital (144)
Weight loss (611)
Women's health (150)
Worklife (25)
Date
Today (100)
Last 7 days (480)
Last 30 days (2168)
Last 365 days (33380)
2026 (19197)
2025 (33213)
2024 (37864)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1299)
Alabama (105)
Alaska (7)
Arizona (419)
Arkansas (16)
Asia (52519)
Australia (9232)
California (14905)
Canada (4175)
China (1692)
Colorado (641)
Connecticut (655)
Delaware (462)
Europe (121108)
Florida (2246)
Georgia (485)
Hawaii (4)
Idaho (70)
Illinois (1307)
India (114)
Indiana (687)
Iowa (25)
Japan (638)
Kansas (146)
Kentucky (58)
Louisiana (64)
Maine (92)
Maryland (1790)
Massachusetts (10886)
Michigan (430)
Minnesota (832)
Mississippi (7)
Missouri (169)
Montana (37)
Nebraska (31)
Nevada (160)
New Hampshire (92)
New Jersey (3941)
New Mexico (36)
New York (3936)
North Carolina (1972)
North Dakota (11)
Northern California (7460)
Ohio (468)
Oklahoma (29)
Oregon (46)
Pennsylvania (2913)
Puerto Rico (33)
Rhode Island (54)
South America (1671)
South Carolina (92)
South Dakota (2)
Southern California (5885)
Tennessee (243)
Texas (2422)
United States (53207)
Utah (449)
Vermont (2)
Virginia (375)
Washington D.C. (88)
Washington State (1209)
West Virginia (4)
Wisconsin (164)
Wyoming (2)
There are 886,570 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Summit has less than a year of cash runway left as PD-1/VEGF verdict nears
Summit’s star asset is the PD-1/VEGF bispecific ivonescimab, which this week produced promising survival data from a late-stage global trial in non-small cell lung cancer. The FDA review is ongoing with a decision expected by Nov. 14.
July 24, 2026
·
2 min read
·
Tristan Manalac
Obesity
Roche cans one Carmot obesity asset as another shows best-in-class potential
Acmopatide met the main goal of a Phase 2 study in type 1 diabetes, but Roche is axing the investigational drug to prioritize enicepatide for weight loss, type 2 diabetes and cardiovascular outcomes. Both assets come from the $2.7 billion buy of Carmot Therapeutics.
July 24, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Icahn Enterprises L.P. Announces Q2 2026 Earnings Conference Call
July 24, 2026
·
1 min read
Press Releases
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
July 24, 2026
·
11 min read
Press Releases
Cytokinetics to Announce Second Quarter Results on August 6, 2026
July 24, 2026
·
3 min read
Press Releases
Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026
July 24, 2026
·
1 min read
Press Releases
MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
July 24, 2026
·
7 min read
Press Releases
Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026
July 24, 2026
·
3 min read
Press Releases
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
July 24, 2026
·
6 min read
Press Releases
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
July 24, 2026
·
1 min read
1 of 88,657
Next
